Immuneoncia Therapeutics Inc
424870
Company Profile
Business description
Immuneoncia Therapeutics Inc is an immuno-oncology-centric biopharmaceutical company. The company focuses on developing immunotherapies for cancer treatment.
Contact
25, Tapsil-ro 35beon-gil
Giheung-gu, Yongin-si
Gyeonggi-do17084
KORT: +82 262835096
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2026
Employees
25
Stocks News & Analysis
stocks
Lithium’s latest drop and what it means for ASX investors
Volatility returns to the lithium market.
stocks
Major ASX miner remains overvalued following production update
Iron ore strength keeps production on track despite lower copper output.
stocks
Ahead of earnings, is Alphabet stock a buy, a sell, or fairly valued?
From Google Cloud to Gemini user retention, here’s what we expect from Alphabet’s earnings report.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,968.50 | 25.00 | 0.28% |
| CAC 40 | 8,340.11 | 1.30 | 0.02% |
| DAX 40 | 24,846.69 | 15.71 | 0.06% |
| Dow JONES (US) | 51,839.26 | 307.16 | -0.59% |
| FTSE 100 | 10,524.76 | 75.61 | -0.71% |
| HKSE | 25,066.65 | 76.40 | -0.30% |
| NASDAQ | 25,508.07 | 12.17 | -0.05% |
| Nikkei 225 | 65,255.68 | 1,114.56 | 1.74% |
| NZX 50 Index | 13,678.86 | 17.17 | -0.13% |
| S&P 500 | 7,443.28 | 14.41 | -0.19% |
| S&P/ASX 200 | 8,785.40 | 28.40 | 0.32% |
| SSE Composite Index | 3,808.97 | 12.69 | 0.33% |